Oncimmune Holdings plc (LON:ONC – Get Free Report) was down 17.7% during trading on Monday . The company traded as low as GBX 18.10 ($0.24) and last traded at GBX 18.10 ($0.24). Approximately 117,187 shares changed hands during mid-day trading, an increase of 22% from the average daily volume of 96,160 shares. The stock had previously closed at GBX 22 ($0.29).
Oncimmune Price Performance
The company has a current ratio of 1.13, a quick ratio of 0.63 and a debt-to-equity ratio of 806.85. The business’s fifty day moving average is GBX 14.52 and its 200 day moving average is GBX 17.89. The firm has a market capitalization of £13.98 million, a P/E ratio of -646.67 and a beta of 1.19.
About Oncimmune
Oncimmune Holdings plc, an immunodiagnostics company, develops solutions for immuno-oncology, autoimmune disease and infectious diseases in the United Kingdom, North America, Europe, and internationally. It offers EarlyCDT-Lung, an immunodiagnostic blood test for detecting and identifying lung cancer; ImmunoINSIGHTS that enables life science organizations to optimize drug development and delivery; SeroTag discovery arrays for discovering and validating biomarkers for stratifying patients in multiple cancer indications, infectious diseases, and with various autoimmune diseases; and NavigAID, a disease-specific characterization panel.
Recommended Stories
- Five stocks we like better than Oncimmune
- Health Care Stocks Explained: Why You Might Want to Invest
- Galmed Pharmaceuticals Surges 400%: What’s Behind the Explosion?
- Why Invest in 5G? How to Invest in 5G Stocks
- Gold Hits New All-Time Highs: 3 Stocks to Ride the Surge
- The Basics of Support and Resistance
- Intel: Why It’s Time to Reconsider This Beaten-Down Chipmaker
Receive News & Ratings for Oncimmune Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oncimmune and related companies with MarketBeat.com's FREE daily email newsletter.
